These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

982 related items for PubMed ID: 26962221

  • 1. Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds.
    Madani N, Princiotto AM, Easterhoff D, Bradley T, Luo K, Williams WB, Liao HX, Moody MA, Phad GE, Vázquez Bernat N, Melillo B, Santra S, Smith AB, Karlsson Hedestam GB, Haynes B, Sodroski J.
    J Virol; 2016 May 15; 90(10):5031-5046. PubMed ID: 26962221
    [Abstract] [Full Text] [Related]

  • 2. CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies.
    Madani N, Princiotto AM, Schön A, LaLonde J, Feng Y, Freire E, Park J, Courter JR, Jones DM, Robinson J, Liao HX, Moody MA, Permar S, Haynes B, Smith AB, Wyatt R, Sodroski J.
    J Virol; 2014 Jun 15; 88(12):6542-55. PubMed ID: 24696475
    [Abstract] [Full Text] [Related]

  • 3. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N, Princiotto AM, Zhao C, Jahanbakhshsefidi F, Mertens M, Herschhorn A, Melillo B, Smith AB, Sodroski J.
    J Virol; 2017 Feb 01; 91(3):. PubMed ID: 27881646
    [Abstract] [Full Text] [Related]

  • 4. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
    Shen X, Bogers WM, Yates NL, Ferrari G, Dey AK, Williams WT, Jaeger FH, Wiehe K, Sawant S, Alam SM, LaBranche CC, Montefiori DC, Martin L, Srivastava I, Heeney J, Barnett SW, Tomaras GD.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28490585
    [Abstract] [Full Text] [Related]

  • 5. A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies.
    Fetzer I, Davis-Gardner ME, Gardner MR, Alfant B, Weber JA, Prasad NR, Zhou AS, Farzan M.
    J Virol; 2019 Mar 01; 93(5):. PubMed ID: 30541842
    [Abstract] [Full Text] [Related]

  • 6. An HIV-1 Env-Antibody Complex Focuses Antibody Responses to Conserved Neutralizing Epitopes.
    Chen Y, Wilson R, O'Dell S, Guenaga J, Feng Y, Tran K, Chiang CI, Arendt HE, DeStefano J, Mascola JR, Wyatt RT, Li Y.
    J Immunol; 2016 Nov 15; 197(10):3982-3998. PubMed ID: 27815444
    [Abstract] [Full Text] [Related]

  • 7. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S, Kumar R, Deshpande S, Samal S, Shrivastava T, Boliar S, Bansal M, Chaudhary NK, Srikrishnan AK, Murugavel KG, Solomon S, Simek M, Koff WC, Goyal R, Chakrabarti BK, Bhattacharya J.
    J Virol; 2016 Jan 13; 90(7):3446-57. PubMed ID: 26763999
    [Abstract] [Full Text] [Related]

  • 8. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
    Wang Y, O'Dell S, Turner HL, Chiang CI, Lei L, Guenaga J, Wilson R, Martinez-Murillo P, Doria-Rose N, Ward AB, Mascola JR, Wyatt RT, Karlsson Hedestam GB, Li Y.
    J Virol; 2017 Nov 01; 91(21):. PubMed ID: 28835491
    [Abstract] [Full Text] [Related]

  • 9. The first hypervariable region of the gp120 Env glycoprotein defines the neutralizing susceptibility of heterologous human immunodeficiency virus type 1 isolates to neutralizing antibodies elicited by the SF162gp140 immunogen.
    Ching LK, Vlachogiannis G, Bosch KA, Stamatatos L.
    J Virol; 2008 Jan 01; 82(2):949-56. PubMed ID: 18003732
    [Abstract] [Full Text] [Related]

  • 10. Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein.
    van Haaren MM, McCoy LE, Torres JL, Lee W, Cottrell CA, Copps JL, van der Woude P, Yasmeen A, de Taeye SW, Torrents de la Peña A, Moore JP, Burton DR, Klasse PJ, Ward AB, Sanders RW, van Gils MJ.
    J Virol; 2021 Aug 10; 95(17):e0009421. PubMed ID: 34076487
    [Abstract] [Full Text] [Related]

  • 11. Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.
    Ingale J, Tran K, Kong L, Dey B, McKee K, Schief W, Kwong PD, Mascola JR, Wyatt RT.
    J Virol; 2014 Dec 10; 88(24):14002-16. PubMed ID: 25253346
    [Abstract] [Full Text] [Related]

  • 12. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.
    Gift SK, Leaman DP, Zhang L, Kim AS, Zwick MB.
    J Virol; 2017 Dec 15; 91(24):. PubMed ID: 28978711
    [Abstract] [Full Text] [Related]

  • 13. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT, Glenn JA, Lippy A, Stamatatos L.
    J Virol; 2014 Mar 15; 88(5):2645-57. PubMed ID: 24352455
    [Abstract] [Full Text] [Related]

  • 14. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT, Chamcha V, Kesavardhana S, Shen X, Beaumont D, Das R, Wyatt LS, LaBranche CC, Stanfield-Oakley S, Ferrari G, Montefiori DC, Moss B, Tomaras GD, Varadarajan R, Amara RR.
    J Virol; 2018 Mar 01; 92(5):. PubMed ID: 29237847
    [Abstract] [Full Text] [Related]

  • 15. Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.
    Qualls ZM, Choudhary A, Honnen W, Prattipati R, Robinson JE, Pinter A.
    J Virol; 2018 Mar 01; 92(5):. PubMed ID: 29237828
    [Abstract] [Full Text] [Related]

  • 16. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
    Liang Y, Guttman M, Williams JA, Verkerke H, Alvarado D, Hu SL, Lee KK.
    J Virol; 2016 Oct 15; 90(20):9224-36. PubMed ID: 27489265
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.
    Castillo-Menendez LR, Witt K, Espy N, Princiotto A, Madani N, Pacheco B, Finzi A, Sodroski J.
    J Virol; 2018 Jun 15; 92(12):. PubMed ID: 29618643
    [Abstract] [Full Text] [Related]

  • 18. Induction of a Tier-1-Like Phenotype in Diverse Tier-2 Isolates by Agents That Guide HIV-1 Env to Perturbation-Sensitive, Nonnative States.
    Johnson J, Zhai Y, Salimi H, Espy N, Eichelberger N, DeLeon O, O'Malley Y, Courter J, Smith AB, Madani N, Sodroski J, Haim H.
    J Virol; 2017 Aug 01; 91(15):. PubMed ID: 28490588
    [Abstract] [Full Text] [Related]

  • 19. Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.
    Anang S, Richard J, Bourassa C, Goyette G, Chiu TJ, Chen HC, Smith AB, Madani N, Finzi A, Sodroski J.
    J Virol; 2022 Sep 14; 96(17):e0063622. PubMed ID: 35980207
    [Abstract] [Full Text] [Related]

  • 20. Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.
    Kang CY, Hariharan K, Nara PL, Sodroski J, Moore JP.
    J Virol; 1994 Sep 14; 68(9):5854-62. PubMed ID: 7520095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.